skip to primary navigationskip to content
 

£1.3M BHF Programme Grant to support research into aortic aneurysms

last modified Aug 03, 2017 12:41 PM

The BHF has awarded Dr Sanjay Sinha and Dr Paul Bertone a £1,270,000 programme grant over five years to identify new therapeutic strategies for genetically-triggered thoracic aortic aneurysm syndromes (Marfan, Loeys-Dietz, Ehlers-Danlos and ACTA2).

Although rupture or dissection of these aneurysms can have catastrophic consequences, there are no specific medical treatments available - likely due to an incomplete understanding of the molecular mechanisms leading to aortic wall weakness.

Dr Sinha's group has pioneered a human induced pluripotent stem cell (hiPSC)-based in vitro model of Marfan's that recapitulates the aneurysm phenotype and has identified a complex network of signalling defects including p38 mitogen-activated protein kinase as a novel regulator of vascular smooth muscle cell (SMC) death.

Using this unique hiPSC-based model of Marfan and other aortic aneurysm syndromes together with murine models, Dr Sinha's and Dr Bertone's groups will determine common disease-causing pathways and identify potential new treatments.

Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.

 

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Katja Kivinen.